A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants.

NCT05767905 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-06821497 Treatment A
DRUG: PF-06821497 Treatment B
DRUG: PF-06821497 Treatment C
DRUG: PF-06821497 Treatment D
DRUG: PF-06821497 Treatment E
DRUG: PF-06821497 Treatment F

Sponsor

Pfizer